Get the Stockscreener App
3.655
0.41%
-0.025
Aurora Cannabis Inc. stock is traded at $3.655, with a volume of 1.23M.
It is down -0.41% in the last 24 hours and up +39.35% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$3.68
Open:
$3.64
24h Volume:
1.23M
Relative Volume:
0.98
Market Cap:
$231.40M
Revenue:
$267.06M
Net Income/Loss:
$-69.17M
P/E Ratio:
-3.2328
EPS:
-1.1306
Net Cash Flow:
$-22.38M
1W Performance:
+26.82%
1M Performance:
+39.35%
6M Performance:
+1.81%
1Y Performance:
-27.85%
1-Day Range:
$3.62
$3.745
1-Week Range:
$3.26
$3.92
52-Week Range:
$2.56
$6.665
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.655 | 232.98M | 267.06M | -69.17M | -22.38M | -1.1306 |
TAK
Takeda Pharmaceutical Co Adr
|
17.36 | 56.30B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.52 | 42.85B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.59 | 42.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.39 | 30.49B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
506.59 | 21.43B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Is Aurora Cannabis (TSX:ACB) Finding Firmer Ground Now? - Kalkine Media
Aurora Cannabis Stock Drops 3.04% as Investors Weigh Medical Cannabis Growth, International Expansion and Profitability - kalkine.ca
Curaleaf Launches $272 Million Bid for Aurora Cannabis - intellectia.ai
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? - Yahoo Finance
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? - The Motley Fool
Key deals this week: Workday, Diversified Energy, Aurora Cannabis, and more - Seeking Alpha
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here's What This Means for Investors. - 富途牛牛
Aurora Cannabis Inc. stock falls Friday, underperforms market - MarketWatch
Aurora Cannabis Stock in Focus: Curaleaf Bid, Germany Growth, EU-GMP Capacity and Record Medical Cannabis Revenue - kalkine.ca
Aurora Cannabis (TSX:ACB) Consolidates Cannabis Stocks Competitive Positioning - Kalkine Media
Joint Operations: Curaleaf Makes a Play for Aurora Cannabis - MarketBeat
StockTalk | Cannabis Report: Potent Q2 results | 2026-08-14 | Investing News - stockhouse.com
Curaleaf Holdings (CURLF) signals intent for take-over bid of Aurora Cannabis - Stock Titan
Could Aurora Cannabis (TSX:ACB) Navigate Retail Changes? - Kalkine Media
Aurora Cannabis Board to Review Unsolicited Curaleaf Takeover Bid - TipRanks
Curaleaf Plans US$272 Million Hostile Bid for Aurora Cannabis - Investing News Network
Curaleaf’s Takeover Bid Pushes ACB Stock To Hit Its Biggest Single-Day Rally In Nearly 11 Months - Stocktwits
Curaleaf Will Benefit From Acquiring Aurora Cannabis And Increasing Its Operations (CURLF) - Seeking Alpha
Will Canopy Growth Get Acquired? - The Globe and Mail
Aurora Cannabis (NASDAQ:ACB): What Does the Latest Update Mean for Strategic Independence? - Kalkine Media
Aurora Cannabis Inc. Stock Rises 9.6%, Outperforms Market - webull.com
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
Last Week in Weed August 4-12, 2026: Curaleaf Launches $272 Million Hostile Bid for Aurora Cannabis - Cannabis & Tech Today
Is Acquiring Aurora Cannabis a Good Move for Curaleaf? - AOL.com
ACB Stock Alert: What to Know as Curaleaf Announces Takeover Bid for Aurora Cannabis - Barchart.com
Can Aurora Cannabis (TSX:ACB) Extend Recent Market Momentum? - Kalkine Media
Why Could Aurora Cannabis (NASDAQ:ACB) Stand Out as Nasdaq Stays Cautious? - Kalkine Media
Aurora Cannabis: from $18 billion glory to medical focus - Newsweed
Curaleaf announces intended takeover bid for Aurora Cannabis offering $4.00 per share - TradingView
Cannabis MSO Curaleaf Planning Hostile Takeover of Canada’s Aurora Cannabis - Ganjapreneur
Aurora Cannabis Suggests Curaleaf’s Bid Is Capped Too Low - the deep dive
Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt? - The Globe and Mail
Curaleaf takes its Aurora bid public as the two sides dispute what happened in private - MMJDaily
Aurora sees 22% surge on hostile takeover bid from Curaleaf - Mugglehead Investment Magazine
Breaking Cannabis M&A: Curaleaf’s Bid For Aurora Cannabis Goes Public - The Dales Report
Aurora Cannabis Stock Surges as Takeover Interest Fuels Bullish Pressure and Renewed Investor Optimism - kalkine.ca
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors. - The Motley Fool
Aurora Cannabis Rejects Curaleaf’s Claim It Refused to Engage in Acquisition Proposal - Cannabis Business Times
ACB Looks 9.2% Undervalued on GF Value™ Amid Strategic Takeover Talks - GuruFocus
Aurora Cannabis to Review Takeover Bid From Rival Curaleaf - WSJ
Curaleaf looks to buy Aurora Cannabis, takes bid directly to shareholders - globalnews.ca
Aurora Cannabis responds to Curaleaf’s takeover bid proposal By Investing.com - Investing.com Nigeria
Curaleaf May Launch Take-Over Bid for Aurora Cannabis - Cannabis Equipment News
Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share - marketscreener.com
Aurora Cannabis to Form Special Committee to Review Curaleaf Takeover Proposal - Yahoo Finance
Update: Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share - Yahoo Finance
Curaleaf announces takeover bid plan for Aurora Cannabis By Investing.com - Investing.com UK
Aurora Cannabis Forms Special Committee in Response to Curaleaf’s Unsolicited Bid - TipRanks
Aurora Cannabis reviews unsolicited $4/share ta... - Pluang
Curaleaf launches hostile bid to acquire Aurora Cannabis at $4 per share, offering shares plus cash. - Pluang
Aurora Cannabis responds to Curaleaf’s takeover bid proposal - Investing.com
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):